Yesterday the House Appropriations Committee considered the proposed Labor-HHS-Education Appropriati...

Highlights of day five coverage from APA’s Annual Meeting include novel interventions for treating p...

Extended-release naltrexone and sublingual buprenorphine-naloxone appear to be equally safe and effe...

Researchers have long suspected that the level of pain experienced by a patient may increase his or ...

The National Institute on Drug Abuse (NIDA) today released data from its Monitoring the Future surve...

“If we as psychiatrists can embrace addiction as a disease of the brain that disrupts the systems th...

Adding clonidine to buprenorphine treatment increased the duration of abstinence for opioid-dependen...

A new comprehensive research review published this week in the New England Journal of Medicine repor...

Yesterday, the National Institute on Drug Abuse (NIDA) introduced resources to help health care prof...